Patrick Stragier
Directeur/Membre du Conseil chez Dendrogenix SA
Profil
Patrick Stragier is the founder of MaSTherCell SA, which was founded in 2010.
He held the title of COO & CBO from 2010 to 2015.
Currently, he is a Director at Dendrogenix SA and an Investment Manager at Noshaq SA, where he started in 2021.
Previously, he worked as a Director of Clinical Manufacturing at Genzyme Flanders BVBA from 2000 to 2002, as Managing Director at Lonza Verviers from 2002 to 2009, as Cell Therapy Platform Director at BioWin ASBL from 2009 to 2010, as Vice President-Operations at PROMETHERA Biosciences SA from 2015 to 2017, as General Manager at Catalent Belgium SA from 2020 to 2021, and as Chief Transformation Officer at Cell Matters SA from 2021 to 2022.
Postes actifs de Patrick Stragier
Sociétés | Poste | Début |
---|---|---|
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | Private Equity Investor | 01/11/2021 |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | Directeur/Membre du Conseil | - |
Anciens postes connus de Patrick Stragier
Sociétés | Poste | Fin |
---|---|---|
Cell Matters SA
Cell Matters SA BiotechnologyHealth Technology CELL MATTERS SA offers solutions for cryopreserving cells. Its products include Cooling and Warming kit designed to cryopreserve by vitrification process. The company was founded by Delphine Connan, Fabien Ectors and Luc Grobet on June 12, 2017 and is headquartered in Liege, Belgium. | Corporate Officer/Principal | 01/10/2022 |
Catalent Belgium SA
Catalent Belgium SA Pharmaceuticals: MajorHealth Technology Part of Catalent, Inc., Catalent Belgium SA is a Belgian pharmaceutical manufacturing company. The company is based in Brussels, Belgium. The company was founded in 1999. Wim Blendeman has been the CEO of the company since 2019. | Corporate Officer/Principal | 01/08/2021 |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Corporate Officer/Principal | 01/10/2017 |
MaSTherCell SA
MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Fondateur | 01/05/2015 |
BioWin ASBL
BioWin ASBL Miscellaneous Commercial ServicesCommercial Services BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium. | Corporate Officer/Principal | 01/07/2010 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 9 |
---|---|
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | Finance |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Health Technology |
Catalent Belgium SA
Catalent Belgium SA Pharmaceuticals: MajorHealth Technology Part of Catalent, Inc., Catalent Belgium SA is a Belgian pharmaceutical manufacturing company. The company is based in Brussels, Belgium. The company was founded in 1999. Wim Blendeman has been the CEO of the company since 2019. | Health Technology |
Genzyme Flanders BV
Genzyme Flanders BV BiotechnologyHealth Technology Part of Sanofi, Genzyme Flanders BVBA is a Belgian company that develops and manufactures biotherapeutic products. The company is based in Geel, Belgium. | Health Technology |
Lonza Verviers | |
BioWin ASBL
BioWin ASBL Miscellaneous Commercial ServicesCommercial Services BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium. | Commercial Services |
MaSTherCell SA
MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Health Technology |
Cell Matters SA
Cell Matters SA BiotechnologyHealth Technology CELL MATTERS SA offers solutions for cryopreserving cells. Its products include Cooling and Warming kit designed to cryopreserve by vitrification process. The company was founded by Delphine Connan, Fabien Ectors and Luc Grobet on June 12, 2017 and is headquartered in Liege, Belgium. | Health Technology |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | Health Technology |